Cargando…

Development of clinical grade vaccine against SARS to begin

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149181/
http://dx.doi.org/10.2165/00128413-200313850-00003
_version_ 1783520755959463936
collection PubMed
description
format Online
Article
Text
id pubmed-7149181
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-71491812020-04-13 Development of clinical grade vaccine against SARS to begin Inpharma Weekly Media Release Springer International Publishing 2013-02-09 2003 /pmc/articles/PMC7149181/ http://dx.doi.org/10.2165/00128413-200313850-00003 Text en © Adis International Ltd 2003 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Media Release
Development of clinical grade vaccine against SARS to begin
title Development of clinical grade vaccine against SARS to begin
title_full Development of clinical grade vaccine against SARS to begin
title_fullStr Development of clinical grade vaccine against SARS to begin
title_full_unstemmed Development of clinical grade vaccine against SARS to begin
title_short Development of clinical grade vaccine against SARS to begin
title_sort development of clinical grade vaccine against sars to begin
topic Media Release
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149181/
http://dx.doi.org/10.2165/00128413-200313850-00003